List of Tables
Table 1. Primary Myelofibrosis Treatment Market Trends
Table 2. Primary Myelofibrosis Treatment Market Drivers & Opportunity
Table 3. Primary Myelofibrosis Treatment Market Challenges
Table 4. Primary Myelofibrosis Treatment Market Restraints
Table 5. Global Primary Myelofibrosis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Primary Myelofibrosis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Primary Myelofibrosis Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Primary Myelofibrosis Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Primary Myelofibrosis Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Primary Myelofibrosis Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Primary Myelofibrosis Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Primary Myelofibrosis Treatment
Table 13. Global Primary Myelofibrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Myelofibrosis Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Myelofibrosis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Primary Myelofibrosis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Primary Myelofibrosis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Primary Myelofibrosis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Primary Myelofibrosis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Primary Myelofibrosis Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Primary Myelofibrosis Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Primary Myelofibrosis Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Primary Myelofibrosis Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Primary Myelofibrosis Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Primary Myelofibrosis Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Primary Myelofibrosis Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Primary Myelofibrosis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Primary Myelofibrosis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Primary Myelofibrosis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Primary Myelofibrosis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Primary Myelofibrosis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Primary Myelofibrosis Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Primary Myelofibrosis Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Primary Myelofibrosis Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Primary Myelofibrosis Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Primary Myelofibrosis Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Primary Myelofibrosis Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Primary Myelofibrosis Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Primary Myelofibrosis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Primary Myelofibrosis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Primary Myelofibrosis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Primary Myelofibrosis Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Primary Myelofibrosis Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Primary Myelofibrosis Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Primary Myelofibrosis Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Primary Myelofibrosis Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Primary Myelofibrosis Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Primary Myelofibrosis Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Primary Myelofibrosis Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Primary Myelofibrosis Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Primary Myelofibrosis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Primary Myelofibrosis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Primary Myelofibrosis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Primary Myelofibrosis Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Primary Myelofibrosis Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. GSK Company Information
Table 58. GSK Introduction and Business Overview
Table 59. GSK Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. GSK Primary Myelofibrosis Treatment Product Offerings
Table 61. GSK Recent Development
Table 62. AbbVie Company Information
Table 63. AbbVie Introduction and Business Overview
Table 64. AbbVie Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. AbbVie Primary Myelofibrosis Treatment Product Offerings
Table 66. AbbVie Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Novartis Primary Myelofibrosis Treatment Product Offerings
Table 71. Novartis Recent Development
Table 72. Celgene Company Information
Table 73. Celgene Introduction and Business Overview
Table 74. Celgene Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Celgene Primary Myelofibrosis Treatment Product Offerings
Table 76. Celgene Recent Development
Table 77. Grunenthal Company Information
Table 78. Grunenthal Introduction and Business Overview
Table 79. Grunenthal Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Grunenthal Primary Myelofibrosis Treatment Product Offerings
Table 81. Grunenthal Recent Development
Table 82. Incyte Company Information
Table 83. Incyte Introduction and Business Overview
Table 84. Incyte Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Incyte Primary Myelofibrosis Treatment Product Offerings
Table 86. Incyte Recent Development
Table 87. CTI BioPharma Company Information
Table 88. CTI BioPharma Introduction and Business Overview
Table 89. CTI BioPharma Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. CTI BioPharma Primary Myelofibrosis Treatment Product Offerings
Table 91. CTI BioPharma Recent Development
Table 92. Bristol Myers Squibb Company Information
Table 93. Bristol Myers Squibb Introduction and Business Overview
Table 94. Bristol Myers Squibb Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bristol Myers Squibb Primary Myelofibrosis Treatment Product Offerings
Table 96. Bristol Myers Squibb Recent Development
Table 97. Suzhou Zelgen Biopharmaceuticals Company Information
Table 98. Suzhou Zelgen Biopharmaceuticals Introduction and Business Overview
Table 99. Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis Treatment Product Offerings
Table 101. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Primary Myelofibrosis Treatment Downstream Customers
Table 105. Primary Myelofibrosis Treatment Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Myelofibrosis Treatment Product Picture
Figure 2. Global Primary Myelofibrosis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Primary Myelofibrosis Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Primary Myelofibrosis Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Primary Myelofibrosis Treatment Report Years Considered
Figure 7. Global Primary Myelofibrosis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Primary Myelofibrosis Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Myelofibrosis Treatment Revenue in 2023
Figure 10. Primary Myelofibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. JAK 1 Picture
Figure 12. JAK 2 Picture
Figure 13. Others Picture
Figure 14. Global Primary Myelofibrosis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Primary Myelofibrosis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Primary Myelofibrosis Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Primary Myelofibrosis Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Primary Myelofibrosis Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Adults
Figure 20. Product Picture of Children
Figure 21. Global Primary Myelofibrosis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Primary Myelofibrosis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Primary Myelofibrosis Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Primary Myelofibrosis Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Primary Myelofibrosis Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Primary Myelofibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Primary Myelofibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Primary Myelofibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Primary Myelofibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Primary Myelofibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Primary Myelofibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Primary Myelofibrosis Treatment Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Primary Myelofibrosis Treatment Sales Volume (%), (2019-2030)
Figure 38. United States Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. China Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. China Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 56. India Primary Myelofibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Primary Myelofibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 58. India Primary Myelofibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 59. Primary Myelofibrosis Treatment Industrial Chain
Figure 60. Primary Myelofibrosis Treatment Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
